Accolade Inc
(FRA:4NE1)
€
3.16
0.04 (1.28%)
Market Cap: 266.40 Mil
Enterprise Value: 270.67 Mil
PE Ratio: 0
PB Ratio: 0.65
GF Score: 61/100 Accolade Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022 / 02:35PM GMT
Release Date Price:
€11.2
(-0.88%)
Craig Matthew Hettenbach
Morgan Stanley, Research Division - VP
Great. Well, good morning, everyone. Welcome to the 20th Annual Healthcare Conference. Glad to see a lot of faces in person. We're very pleased to host Accolade today, CEO, Raj Singh; and CFO, Steve Barnes. So welcome.
Rajeev Singh
Accolade, Inc. - Chairman of the Board & CEO
Thank you, Craig. Glad to be here.
Craig Matthew Hettenbach
Morgan Stanley, Research Division - VP
So I'm Craig Hettenbach. I focus on the health care technology within the Morgan Stanley services team. Just a quick disclosure before we start. You can see the disclosures at the Morgan Stanley research, www.morganstanley.com\researchdisclosures.
Questions & Answers
Craig Matthew Hettenbach
Morgan Stanley, Research Division - VP
So with that out of the way, I wanted to start with the macro just because it's top of mind for investors. And certainly, if I look back a year ago, tight labor market. You fast
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot